Search

Your search keyword '"IEBBA, VALERIO"' showing total 237 results

Search Constraints

Start Over You searched for: Author "IEBBA, VALERIO" Remove constraint Author: "IEBBA, VALERIO"
237 results on '"IEBBA, VALERIO"'

Search Results

2. Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome

4. WED-540-YI Gender-dependent HCC development in X/MYC mouse model

5. Short-chain fatty acids promote the effect of environmental signals on the gut microbiome and metabolome in mice

6. Does gut microbiota dysbiosis impact the metabolic alterations of hydrogen sulfide and lanthionine in patients with chronic kidney disease?

7. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer

8. Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment

9. Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

10. Multifaceted modes of action of the anticancer probiotic Enterococcus hirae

11. Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patients

12. Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer

13. Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis

15. Data from Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis

16. Supplementary Figure from Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis

19. Cancer induces a stress ileopathy depending on B-adrenergic receptors and promoting dysbiosis that contribute to carcinogenesis

20. Cancer Induces a Stress Ileopathy Depending on beta-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis

21. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in advanced non-small cell lung cancer patients

22. Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis

23. Profiling of Oral Microbiota and Cytokines in COVID-19 Patients

24. Cancer induces a stress ileopathy depending on B-adrenergic receptors and promoting dysbiosis that contribute to carcinogenesis

25. Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage

26. Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade

28. Profiling of oral microbiota and cytokines in COVID-19 patients

29. Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

30. Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patients

31. Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage

32. Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients

33. Structural Variations of Vaginal and Endometrial Microbiota: Hints on Female Infertility

34. Physiologic colonic uptake of 18F-FDG on PET/CT predicts immunotherapy response and gut microbiome diversity in patients with advanced non-small cell lung cancer (NSCLC).

35. Combining amplicon sequencing and metabolomics in cirrhotic patients

36. Nasal microbiota in RSV microbiota

37. Intestinal Akkermansia muciniphilapredicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer

38. A distinctive 'microbial signature' in celiac pediatric patients

40. Postbiotic Protective Activity of Lactobacillus Rhamnosus GG-Derived Factors on Pathogen Lipopolysaccharide (LPS)-Induced Damage of Human Colonic Smooth Muscle

41. Rebuilding the Gut Microbiota Ecosystem

43. 1014 - Microbiota Composition, Metabolic Profiles and Inflammatory Host Response after Fecal Microbiota Transplantation (FMT) for Recurrent Clostridium Difficile Infection. Does Proteobacteria Abundance Predict the Response to FMT?

46. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Allelic Variants Relate to Shifts in Faecal Microbiota of Cystic Fibrosis Patients

47. Characterization of mucosa-associated and fecal microbiota of children with autism spectre disorder

48. Strategie terapeutiche innovative basate sulla duplice attività, antibatterica e probiotica, del predatore batterico Bdellovibrio bacteriovorus

49. Influence of oral conditions on colonization by highly toxigenic Staphylococcus aureus strains

50. Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in fecal microbiota of cystic fibrosis patients

Catalog

Books, media, physical & digital resources